Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerzy-Roch Nofer

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Current Opinion in Lipidology|May 12, 2012
Hyperlipidaemia and cardiovascular disease: HDL, inflammation and surprising results of AIM-HIGH studyJerzy-Roch Nofer
Current Opinion in Lipidology|July 14, 2010
Hyperlipidemia and cardiovascular disease: should we abandon HDL cholesterol as a therapeutic target in coronary heart diseaseJerzy-Roch Nofer
Current Opinion in Lipidology|July 12, 2011
Hyperlipidemia and cardiovascular disease: triglycerides - a revival of cardiovascular risk factor?Jerzy-Roch Nofer
Journal of Molecular Endocrinology|February 23, 2012
Estrogens and atherosclerosis: insights from animal models and cell systemsJerzy-Roch Nofer
Journal of Clinical Lipidology|February 5, 2011
High-density lipoprotein, sphingosine 1-phosphate, and atherosclerosisJerzy-Roch Nofer
Current Opinion in Lipidology|July 11, 2013
Hyperlipidaemia and cardiovascular disease: the quantity does not turn into quality!Jerzy-Roch Nofer
Handbook of Experimental Pharmacology|December 20, 2014
Signal transduction by HDL: agonists, receptors, and signaling cascadesJerzy-Roch Nofer
Annual Review of Medicine|November 5, 2002
Atheroprotective effects of high-density lipoproteinsGerd Assmann, Jerzy-Roch Nofer
Trends in Cardiovascular Medicine|October 18, 2005
Atheroprotective effects of high-density lipoprotein-associated lysosphingolipidsJerzy-Roch Nofer, Gerd Assmann
Current Opinion in Lipidology|May 4, 2011
HDL scavenger receptor class B type I and platelet functionJerzy-Roch Nofer, Miranda van Eck
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Current Opinion in Lipidology|May 12, 2012
Hyperlipidaemia and cardiovascular disease: HDL, inflammation and surprising results of AIM-HIGH studyJerzy-Roch Nofer
Current Opinion in Lipidology|July 14, 2010
Hyperlipidemia and cardiovascular disease: should we abandon HDL cholesterol as a therapeutic target in coronary heart diseaseJerzy-Roch Nofer
Current Opinion in Lipidology|July 12, 2011
Hyperlipidemia and cardiovascular disease: triglycerides - a revival of cardiovascular risk factor?Jerzy-Roch Nofer
Journal of Molecular Endocrinology|February 23, 2012
Estrogens and atherosclerosis: insights from animal models and cell systemsJerzy-Roch Nofer
Journal of Clinical Lipidology|February 5, 2011
High-density lipoprotein, sphingosine 1-phosphate, and atherosclerosisJerzy-Roch Nofer
Current Opinion in Lipidology|July 11, 2013
Hyperlipidaemia and cardiovascular disease: the quantity does not turn into quality!Jerzy-Roch Nofer
Handbook of Experimental Pharmacology|December 20, 2014
Signal transduction by HDL: agonists, receptors, and signaling cascadesJerzy-Roch Nofer
Annual Review of Medicine|November 5, 2002
Atheroprotective effects of high-density lipoproteinsGerd Assmann, Jerzy-Roch Nofer
Trends in Cardiovascular Medicine|October 18, 2005
Atheroprotective effects of high-density lipoprotein-associated lysosphingolipidsJerzy-Roch Nofer, Gerd Assmann
Current Opinion in Lipidology|May 4, 2011
HDL scavenger receptor class B type I and platelet functionJerzy-Roch Nofer, Miranda van Eck
Pageof 10